132 related articles for article (PubMed ID: 1975622)
1. Effect of Phe-D-Met-Arg-Phe-NH2 and other Phe-Met-Arg-Phe-NH2-related peptides on mouse colonic propulsive motility: a structure-activity relationship study.
Raffa RB; Jacoby HI
J Pharmacol Exp Ther; 1990 Sep; 254(3):809-14. PubMed ID: 1975622
[TBL] [Abstract][Full Text] [Related]
2. [D-Met2]-FMRFamide (DMFa): production of naloxone-sensitive antinociception in mouse tail-flick test.
Raffa RB; Connelly CD
NIDA Res Monogr; 1990; 105():391-2. PubMed ID: 1876049
[TBL] [Abstract][Full Text] [Related]
3. The effect of Phe-Met-Arg-Phe-NH2 (FMRFamide) on morphine-induced inhibition of colonic propulsive motility in mice.
Jacoby MB; Jacoby HI; Mathiasen JR; Raffa RB
Neurosci Lett; 1987 Dec; 83(1-2):128-32. PubMed ID: 3441291
[TBL] [Abstract][Full Text] [Related]
4. The actions of FMRF-NH2 and FMRF-NH2 related peptides on mammals.
Raffa RB
NIDA Res Monogr; 1990; 105():243-9. PubMed ID: 1678861
[TBL] [Abstract][Full Text] [Related]
5. A-18-famide and F-8-famide, endogenous mammalian equivalents of the molluscan neuropeptide FMRFamide (Phe-Met-Arg-Phe-NH2), inhibit colonic bead expulsion time in mice.
Raffa RB; Jacoby HI
Peptides; 1989; 10(4):873-5. PubMed ID: 2587427
[TBL] [Abstract][Full Text] [Related]
6. Comparative action of Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 analogs on intestinal motility and nociception in rats.
Million M; Fioramonti J; Gicquel S; Zajac JM; Bueno L
J Pharmacol Exp Ther; 1993 Apr; 265(1):96-102. PubMed ID: 8474035
[TBL] [Abstract][Full Text] [Related]
7. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
[TBL] [Abstract][Full Text] [Related]
8. Supraspinal antinociception produced by [D-Met2]-FMRFamide in mice.
Raffa RB; Connelly CD
Neuropeptides; 1992 Jul; 22(3):195-203. PubMed ID: 1331846
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide FF receptors: structure-activity relationship and effect of morphine.
Payza K; Akar CA; Yang HY
J Pharmacol Exp Ther; 1993 Oct; 267(1):88-94. PubMed ID: 8229791
[TBL] [Abstract][Full Text] [Related]
10. Supraspinal administration of [D-Met2]FMRFamide produces a naloxone-sensitive increase in heart rate in unrestrained spontaneously hypertensive rats.
Raffa RB; Addo MF; Gill A
Neuropeptides; 1992 Apr; 21(4):201-5. PubMed ID: 1355596
[TBL] [Abstract][Full Text] [Related]
11. The action of FMRFamide (Phe-Met-Arg-Phe-NH2) and related peptides on mammals.
Raffa RB
Peptides; 1988; 9(4):915-22. PubMed ID: 3067224
[TBL] [Abstract][Full Text] [Related]
12. Low affinity of FMRFamide and four FaRPs (FMRFamide-related peptides), including the mammalian-derived FaRPs F-8-Famide (NPFF) and A-18-Famide, for opioid mu, delta, kappa 1, kappa 2a, or kappa 2b receptors.
Raffa RB; Kim A; Rice KC; de Costa BR; Codd EE; Rothman RB
Peptides; 1994; 15(3):401-4. PubMed ID: 7937312
[TBL] [Abstract][Full Text] [Related]
13. Dissociation of opioid antinociception and central gastrointestinal propulsion in the mouse: studies with naloxonazine.
Heyman JS; Williams CL; Burks TF; Mosberg HI; Porreca F
J Pharmacol Exp Ther; 1988 Apr; 245(1):238-43. PubMed ID: 2834537
[TBL] [Abstract][Full Text] [Related]
14. Peptide opioid antagonist separates peripheral and central opioid antitransit effects.
Shook JE; Pelton JT; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1987 Nov; 243(2):492-500. PubMed ID: 2824748
[TBL] [Abstract][Full Text] [Related]
15. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.
Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324
[TBL] [Abstract][Full Text] [Related]
16. Development of potent thrombin receptor antagonist peptides.
Bernatowicz MS; Klimas CE; Hartl KS; Peluso M; Allegretto NJ; Seiler SM
J Med Chem; 1996 Dec; 39(25):4879-87. PubMed ID: 8960546
[TBL] [Abstract][Full Text] [Related]
17. Antinociceptive effects of intrathecally administered F8Famide and FMRFamide in the rat.
Gouardères C; Sutak M; Zajac JM; Jhamandas K
Eur J Pharmacol; 1993 Jun; 237(1):73-81. PubMed ID: 8102975
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory influences of mammalian FMRFamide (Phe-Met-Arg-Phe-amide)-related peptides on nociception and morphine- and stress-induced analgesia in mice.
Kavaliers M
Neurosci Lett; 1990 Jul; 115(2-3):307-12. PubMed ID: 2234508
[TBL] [Abstract][Full Text] [Related]
19. Centrally administered bombesin affects gastrointestinal transit and colonic bead expulsion through supraspinal mechanisms.
Koslo RJ; Burks TF; Porreca F
J Pharmacol Exp Ther; 1986 Jul; 238(1):62-7. PubMed ID: 3755171
[TBL] [Abstract][Full Text] [Related]
20. The molluscan neurosecretory peptide FMRFamide: comparative pharmacology and relationship to the enkephalins.
Greenberg MJ; Painter SD; Doble KE; Nagle GT; Price DA; Lehman HK
Fed Proc; 1983 Jan; 42(1):82-6. PubMed ID: 6129162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
